Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Jan;37(1):100–105. doi: 10.1128/aac.37.1.100

Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Y Iizawa 1, K Okonogi 1, R Hayashi 1, T Iwahi 1, T Yamazaki 1, A Imada 1
PMCID: PMC187612  PMID: 8431004

Abstract

The therapeutic effect of cefozopran (SCE-2787), a new semisynthetic parenteral cephalosporin, against experimental infections in mice was examined. Cefozopran was more effective than cefpiramide and was as effective as ceftazidime and cefpirome against acute respiratory tract infections caused by Klebsiella pneumoniae DT-S. In the model of chronic respiratory tract infection caused by K. pneumoniae 27, cefozopran was as effective as ceftazidime. The therapeutic effect of cefozopran against urinary tract infections caused by Pseudomonas aeruginosa P9 was superior to that of cefpirome and was equal to those of ceftazidime and cefclidin. In addition, cefozopran was more effective than ceftazidime and was as effective as flomoxef in a thigh muscle infection caused by methicillin-sensitive Staphylococcus aureus 308A-1. Against thigh muscle infections caused by methicillin-resistant S. aureus N133, cefozopran was the most effective agent. The potent therapeutic effect of cefozopran in those experimental infections in mice suggests that it would be effective against respiratory tract, urinary tract, and soft tissue infections caused by a variety of gram-positive and gram-negative bacteria in humans.

Full text

PDF
100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker-Woudenberg I. A., van den Berg J. C., Michel M. F. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother. 1982 Dec;22(6):1042–1050. doi: 10.1128/aac.22.6.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berendt R. F., Long G. G., Walker J. S. Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother. 1975 Nov;8(5):585–590. doi: 10.1128/aac.8.5.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boon R. J., Beale A. S., Comber K. R., Pierce C. V., Sutherland R. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections. Antimicrob Agents Chemother. 1982 Sep;22(3):369–375. doi: 10.1128/aac.22.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Girard A. E., Girard D., English A. R., Gootz T. D., Cimochowski C. R., Faiella J. A., Haskell S. L., Retsema J. A. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother. 1987 Dec;31(12):1948–1954. doi: 10.1128/aac.31.12.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goessens W. H., Fontijne P., Michel M. F. Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice. Antimicrob Agents Chemother. 1984 Dec;26(6):829–832. doi: 10.1128/aac.26.6.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Haller I. Evaluation of ciprofloxacin alone and in combination with other antibiotics in a murine model of thigh muscle infection. Am J Med. 1987 Apr 27;82(4A):76–79. [PubMed] [Google Scholar]
  7. Iizawa Y., Nishi T., Kondo M., Imada A. Experimental chronic pulmonary infection in mice caused by Klebsiella pneumoniae. Microbiol Immunol. 1988;32(9):895–906. doi: 10.1111/j.1348-0421.1988.tb01451.x. [DOI] [PubMed] [Google Scholar]
  8. Iwahi T., Okonogi K., Yamazaki T., Shiki S., Kondo M., Miyake A., Imada A. In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother. 1992 Jul;36(7):1358–1366. doi: 10.1128/aac.36.7.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KING E. O., WARD M. K., RANEY D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med. 1954 Aug;44(2):301–307. [PubMed] [Google Scholar]
  10. Kita Y., Yamazaki T., Imada A. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals. Antimicrob Agents Chemother. 1992 Nov;36(11):2481–2486. doi: 10.1128/aac.36.11.2481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Klesel N., Isert D., Limbert M., Markus A., Seibert G., Schrinner E. Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections. J Antibiot (Tokyo) 1990 Jan;43(1):100–106. doi: 10.7164/antibiotics.43.100. [DOI] [PubMed] [Google Scholar]
  12. Matsui H., Yano K., Okuda T. Pharmacokinetics of the cephalosporin SM-1652 in mice, rats, rabbits, dogs, and rhesus monkeys. Antimicrob Agents Chemother. 1982 Aug;22(2):213–217. doi: 10.1128/aac.22.2.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McColm A. A., Shelley E., Ryan D. M., Acred P. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions. J Antimicrob Chemother. 1986 Nov;18(5):599–608. doi: 10.1093/jac/18.5.599. [DOI] [PubMed] [Google Scholar]
  14. Nakao M., Noji Y., Iwahi T., Yamazaki T. Antibacterial properties of SCE-2787, a new cephem antibiotic. J Antimicrob Chemother. 1992 May;29(5):509–518. doi: 10.1093/jac/29.5.509. [DOI] [PubMed] [Google Scholar]
  15. Nishi T., Tsuchiya K. Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin. Antimicrob Agents Chemother. 1980 Mar;17(3):494–505. doi: 10.1128/aac.17.3.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nishi T., Tsuchiya K. Experimental urinary tract infection with Pseudomonas aeruginosa in mice. Infect Immun. 1978 Nov;22(2):508–515. doi: 10.1128/iai.22.2.508-515.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nishi T., Tsuchiya K. Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice. Antimicrob Agents Chemother. 1980 Oct;18(4):549–556. doi: 10.1128/aac.18.4.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rolin O., Huet Y., Bouanchaud D. H. Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses. J Antimicrob Chemother. 1986 Apr;17 (Suppl B):49–52. doi: 10.1093/jac/17.suppl_b.49. [DOI] [PubMed] [Google Scholar]
  19. SELBIE F. R., SIMON R. D. Virulence to mice of Staphylococcus pyogenes: its measurement and its relation to certain in vitro properties. Br J Exp Pathol. 1952 Aug;33(4):315–326. [PMC free article] [PubMed] [Google Scholar]
  20. Unowsky J., Chandrasekar P. H., DeLorenzo W., Levine D. P. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus. Chemotherapy. 1986;32(6):499–505. doi: 10.1159/000238459. [DOI] [PubMed] [Google Scholar]
  21. Vogelman B., Gudmundsson S., Turnidge J., Leggett J., Craig W. A. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis. 1988 Feb;157(2):287–298. doi: 10.1093/infdis/157.2.287. [DOI] [PubMed] [Google Scholar]
  22. Warren J. W., Tenney J. H., Hoopes J. M., Muncie H. L., Anthony W. C. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982 Dec;146(6):719–723. doi: 10.1093/infdis/146.6.719. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES